ENTvantage Diagnostics Inc.
Point-of-care diagnostic for sinusitis avoids antibiotic overuse
This article was originally published in Start Up
Sinusitis is one malady that is prone to antibiotic overuse - antibiotics are prescribed for some 50% of patients, partly because busy physicians don’t feel they have the time to explain to them why an antibiotic is not appropriate. ENTvantage Diagnostics Inc. is developing a point-of-care diagnostic to quickly determine whether patients have bacterial or viral sinusitis.
You may also be interested in...
For innovators in the medical device industry, the otolaryngology or ENT (ear, nose, and throat) specialty offers just about everything that investors look for these days. Profiles of Aerin Medical, Spirox, Fiagon AG Medical, and ENTvantage Diagnostics.
The German biotech plans to prevent chemotherapy-induced hearing loss and treat chronic hearing loss by targeting a potassium channel in the ear’s sensory hair cells as it tackles a widespread but side-lined area.
The Irish firm revealed it was in early conversations with Amgen, J&J and Sanofi regarding a possible takeover, with some experts touting the potential for a deal far surpassing the $20bn mark.